GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RYAH Group Inc (XCNQ:RYAH) » Definitions » Debt-to-Revenue

RYAH Group (XCNQ:RYAH) Debt-to-Revenue : 6.64 (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is RYAH Group Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

RYAH Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was C$0.03 Mil. RYAH Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was C$0.26 Mil. RYAH Group's annualized Revenue for the quarter that ended in Sep. 2022 was C$0.04 Mil. RYAH Group's annualized Debt-to-Revenue for the quarter that ended in Sep. 2022 was 6.64.


RYAH Group Debt-to-Revenue Historical Data

The historical data trend for RYAH Group's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RYAH Group Debt-to-Revenue Chart

RYAH Group Annual Data
Trend Dec20 Dec21
Debt-to-Revenue
22.89 0.12

RYAH Group Quarterly Data
Feb20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Debt-to-Revenue Get a 7-Day Free Trial 7.00 0.08 N/A 0.69 6.64

Competitive Comparison of RYAH Group's Debt-to-Revenue

For the Health Information Services subindustry, RYAH Group's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RYAH Group's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RYAH Group's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where RYAH Group's Debt-to-Revenue falls into.



RYAH Group Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

RYAH Group's Debt-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.026 + 0) / 0.215
=0.12

RYAH Group's annualized Debt-to-Revenue for the quarter that ended in Sep. 2022 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.028 + 0.264) / 0.044
=6.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2022) Revenue data.


RYAH Group Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of RYAH Group's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


RYAH Group (XCNQ:RYAH) Business Description

Traded in Other Exchanges
N/A
Address
68 34TH STREET, SUITE B421, BROOKLYN, NY, USA, 11232
RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.

RYAH Group (XCNQ:RYAH) Headlines

No Headlines